XML 66 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation And Employee Benefit Plans (Tables)
 12 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule Of Assumptions Used In The Black-Scholes Valuation Model
The estimated assumptions used in the Black-Scholes valuation model to value our ESPP purchase rights were as follows:
 ESPP Purchase Rights
 Year Ended March 31,
 202420232022
Risk-free interest rate
5.0 - 5.5%
3.1 - 5.0%
0.1% - 1.1%
Expected volatility
19 - 24%
27 - 31%
25 - 30%
Weighted-average volatility
23%
29%
27%
Expected term
6 - 12 months
6 - 12 months
6 - 12 months
Expected dividends
0.8%
0.8 %0.6 %
Schedule Of Assumptions Used In Monte-Carlo Simulation Model
The assumptions used in the Monte-Carlo simulation model to value our market-based restricted stock units were as follows:
 Year Ended March 31,
202420232022
Risk-free interest rate
4.4%
3.3 %
0.4%
Expected volatility
25 - 59%
33 - 56%
24 - 76%
Weighted-average volatility
39%
43%
40%
Expected dividendsNoneNoneNone
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
The following table summarizes our stock option activity for the fiscal year ended March 31, 2024:
Options
(in thousands)		Weighted-
Average
Exercise Prices		Weighted-
Average
Remaining
Contractual
Term  (in years)		Aggregate
Intrinsic Value
(in millions)
Outstanding as of March 31, 2023
121 $40.43 
Granted3 131.04 
Exercised(112)40.49 
Forfeited, cancelled or expired— — 
Outstanding as of March 31, 2024
12 $64.00 3.95$1 
Vested and expected to vest12 $64.00 3.95$1 
Exercisable as of March 31, 2024
12 $64.00 3.95$1 
The following table summarizes our restricted stock units activity, excluding performance-based and market-based restricted stock unit activity which is discussed below, for the fiscal year ended March 31, 2024:
Restricted
Stock Units
(in thousands)		Weighted-
Average Grant
Date Fair Values
Outstanding as of March 31, 2023
7,502 $128.54 
Granted4,798 129.30 
Vested(4,015)129.71 
Forfeited or cancelled(805)129.37 
Outstanding as of March 31, 2024
7,480 $128.31 
The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the fiscal year ended March 31, 2024:
Performance-
Based Restricted
Stock Units
(in thousands)		Weighted-
Average Grant
Date Fair Value
Outstanding as of March 31, 2023
557 $130.03 
Granted682 128.66 
Vested(73)127.98 
Forfeited or cancelled(330)128.74 
Outstanding as of March 31, 2024
836 $129.60 
The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the year ended March 31, 2024:
Market-Based
Restricted  Stock
Units
(in thousands)		Weighted-
Average  Grant
Date Fair Value
Outstanding as of March 31, 2023
822 $149.98 
Granted143 152.92 
Vested(50)125.62 
Forfeited or cancelled(561)141.20 
Outstanding as of March 31, 2024
354 $168.53 
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity
The following table summarizes our ESPP activity for fiscal years ended March 31, 2024, 2023, and 2022:
Shares Issued
(in millions)		Exercise Prices for Purchase RightsWeighted-Average Fair Values of Purchase Rights
Fiscal Year 2022
0.6 
$113.39 - $118.14
$35.94 
Fiscal Year 2023
0.7 
$96.34 - $111.86
$33.91 
Fiscal Year 2024
0.8 
$94.96 - $102.58
$30.82 
Schedule Of Stock-Based Compensation Expense By Statement Of Operations
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Consolidated Statements of Operations (in millions):
 Year Ended March 31,
 202420232022
Cost of revenue$8 $7 $6 
Research and development418 367 356 
Marketing and sales52 59 54 
General and administrative106 115 112 
Stock-based compensation expense$584 $548 $528 
Shares Repurchased and Retired
The following table summarizes total shares repurchased during fiscal years 2024, 2023, and 2022:
November 2020 ProgramAugust 2022 ProgramTotal
(In millions)SharesAmountShares
Amount(a)
SharesAmount
Fiscal Year 2022
9.5 $1,300 — $— 9.5 $1,300 
Fiscal Year 2023
5.1 $650 5.3 $645 10.4 $1,295 
Fiscal Year 2024
— $— 10.0 $1,300 10.0 $1,300 
(a)Amount excludes excise taxes. Accrued excise taxes are included in accrued and other current liabilities and additional paid-in capital on the Consolidated Balance Sheets.